Creon
Creon is a pharmaceutical drug with 15 clinical trials. Historical success rate of 70.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
2
Early Stage
2
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
53.8%
7 of 13 finished
46.2%
6 ended early
0
trials recruiting
15
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Effect of Enzyme Therapy on Protein Metabolism in Chronic Pancreatitis
Pancreatic Enzyme Replacement and Glucose Regulation in Type 1 Diabetes
Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon
Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms
Clinical Trials (15)
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Effect of Enzyme Therapy on Protein Metabolism in Chronic Pancreatitis
Pancreatic Enzyme Replacement and Glucose Regulation in Type 1 Diabetes
Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With Creon
Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms
CREON for the Treatment of Post-RYGB Hypoglycemia
Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two Drugs
Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Creon Use in Coeliac Patients With Low Faecal Pancreatic Elastase
A Double-blind, Randomized, Multicenter, Cross-over Study to Compare the Effect of Creon N and Creon® on Fat Digestion in Subjects ≥ 12 Years of Age With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis
A Study to Assess the Effect of Creon® on Pancreatic Exocrine Insufficiency in Subjects With Diabetes Mellitus Type 2
Creon After Pancreatic Surgery
Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency
Evaluation of the Digestive and Metabolic Utilisation of Dietary Protein in Patients With Chronic Pancreatitis
All 15 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 15